Cargando…

Long-acting Paliperidone Palmitate treatment in an Ekbom’s Syndrome secondary to Lewy Body Dementia: A case report

INTRODUCTION: Ekbom Syndrome (ES) is a condition characterized by the fixed, delusional belief that one’s body is infested by parasites or other vermin, in absence of supporting clinical evidence. Literature suggests antipsychotic treatment for the management of behavioural and psychotic symptomatol...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsolini, L., Corona, D., Giordani, M., Salvi, V., Volpe, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568182/
http://dx.doi.org/10.1192/j.eurpsy.2022.1211
_version_ 1784809584735551488
author Orsolini, L.
Corona, D.
Giordani, M.
Salvi, V.
Volpe, U.
author_facet Orsolini, L.
Corona, D.
Giordani, M.
Salvi, V.
Volpe, U.
author_sort Orsolini, L.
collection PubMed
description INTRODUCTION: Ekbom Syndrome (ES) is a condition characterized by the fixed, delusional belief that one’s body is infested by parasites or other vermin, in absence of supporting clinical evidence. Literature suggests antipsychotic treatment for the management of behavioural and psychotic symptomatology, long-acting-injectable (LAI) antipsychotics for poor compliance. OBJECTIVES: A case report of a 70-year-old woman with an ES diagnosis treated with LAI palmitate paliperidone was followed-up for an 8-months period, resulting in a confirmed diagnosis of secondary ES to Lewy Body Dementia (LBD). METHODS: Patient was admitted to the local psychiatry ward presenting with new-onset visual and tactile hallucinations and social withdrawal. She was diagnosed with ES in a context of executive functions impairment. She was initially treated with risperidone, then switched to LAI Paliperidone due to poor compliance. Subsequently she was monitored monthly for 8 months by administering PANSS, MOCA, GAF, BPRS, PSP, complete neurocognitive assessment and neuroimaging studies RESULTS: After 8 months a progressive cognitive deterioration and worsening of motor impairment confirmed a secondary ES to a LBD. Meanwhile, a significant reduction of psychotic symptomatology (delusions and somatic hallucinations) was observed at BPRS and PANSS positive scale, even after treatment discontinuation due to the onset of extrapyramidal symptoms of the underlying condition. CONCLUSIONS: LAI Paliperidone treatment induced a complete remission of psychotic symptoms, with no relapse even after discontinuation of treatment. Moreover, close observation during follow-up allowed early diagnosis of LBD, which has been associated with a more favorable course. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9568182
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95681822022-10-17 Long-acting Paliperidone Palmitate treatment in an Ekbom’s Syndrome secondary to Lewy Body Dementia: A case report Orsolini, L. Corona, D. Giordani, M. Salvi, V. Volpe, U. Eur Psychiatry Abstract INTRODUCTION: Ekbom Syndrome (ES) is a condition characterized by the fixed, delusional belief that one’s body is infested by parasites or other vermin, in absence of supporting clinical evidence. Literature suggests antipsychotic treatment for the management of behavioural and psychotic symptomatology, long-acting-injectable (LAI) antipsychotics for poor compliance. OBJECTIVES: A case report of a 70-year-old woman with an ES diagnosis treated with LAI palmitate paliperidone was followed-up for an 8-months period, resulting in a confirmed diagnosis of secondary ES to Lewy Body Dementia (LBD). METHODS: Patient was admitted to the local psychiatry ward presenting with new-onset visual and tactile hallucinations and social withdrawal. She was diagnosed with ES in a context of executive functions impairment. She was initially treated with risperidone, then switched to LAI Paliperidone due to poor compliance. Subsequently she was monitored monthly for 8 months by administering PANSS, MOCA, GAF, BPRS, PSP, complete neurocognitive assessment and neuroimaging studies RESULTS: After 8 months a progressive cognitive deterioration and worsening of motor impairment confirmed a secondary ES to a LBD. Meanwhile, a significant reduction of psychotic symptomatology (delusions and somatic hallucinations) was observed at BPRS and PANSS positive scale, even after treatment discontinuation due to the onset of extrapyramidal symptoms of the underlying condition. CONCLUSIONS: LAI Paliperidone treatment induced a complete remission of psychotic symptoms, with no relapse even after discontinuation of treatment. Moreover, close observation during follow-up allowed early diagnosis of LBD, which has been associated with a more favorable course. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9568182/ http://dx.doi.org/10.1192/j.eurpsy.2022.1211 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Orsolini, L.
Corona, D.
Giordani, M.
Salvi, V.
Volpe, U.
Long-acting Paliperidone Palmitate treatment in an Ekbom’s Syndrome secondary to Lewy Body Dementia: A case report
title Long-acting Paliperidone Palmitate treatment in an Ekbom’s Syndrome secondary to Lewy Body Dementia: A case report
title_full Long-acting Paliperidone Palmitate treatment in an Ekbom’s Syndrome secondary to Lewy Body Dementia: A case report
title_fullStr Long-acting Paliperidone Palmitate treatment in an Ekbom’s Syndrome secondary to Lewy Body Dementia: A case report
title_full_unstemmed Long-acting Paliperidone Palmitate treatment in an Ekbom’s Syndrome secondary to Lewy Body Dementia: A case report
title_short Long-acting Paliperidone Palmitate treatment in an Ekbom’s Syndrome secondary to Lewy Body Dementia: A case report
title_sort long-acting paliperidone palmitate treatment in an ekbom’s syndrome secondary to lewy body dementia: a case report
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568182/
http://dx.doi.org/10.1192/j.eurpsy.2022.1211
work_keys_str_mv AT orsolinil longactingpaliperidonepalmitatetreatmentinanekbomssyndromesecondarytolewybodydementiaacasereport
AT coronad longactingpaliperidonepalmitatetreatmentinanekbomssyndromesecondarytolewybodydementiaacasereport
AT giordanim longactingpaliperidonepalmitatetreatmentinanekbomssyndromesecondarytolewybodydementiaacasereport
AT salviv longactingpaliperidonepalmitatetreatmentinanekbomssyndromesecondarytolewybodydementiaacasereport
AT volpeu longactingpaliperidonepalmitatetreatmentinanekbomssyndromesecondarytolewybodydementiaacasereport